Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU Topicspharmacology

ICU · pharmacology

ICU Antihypertensive Drugs — Comprehensive

Also known as IV antihypertensives · Hypertensive emergency drugs · Labetalol · Nicardipine · Sodium nitroprusside · Clevidipine · Esmolol · Hydralazine · Phentolamine · Fenoldopam · Cyanide toxicity · Unopposed alpha stimulation

IV antihypertensives for the ICU — the nine agents every intensivist must master: LABETALOL (combined alpha+beta blocker — versatile first-line for most hypertensive emergencies; 20 mg IV bolus then 40 mg and 80 mg boluses to a 300 mg maximum in trial protocols; contraindicated in severe asthma/heart block), NICARDIPINE (dihydropyridine CCB — smooth titratable infusion 5-15 mg/h — ideal for most HTN emergencies including stroke), HYDRALAZINE (direct arteriolar vasodilator — pregnancy/pre-eclampsia favourite; 5 mg slow IV bolus repeatable; CAUTION reflex tachycardia), SODIUM NITROPRUSSIDE (arteriolar + venous NO donor — most potent — CYANIDE TOXICITY risk rises with infusion rate, cumulative dose or prolonged infusion — now largely superseded), NITROGLYCERIN (venous arteriolar NO donor — start 5 mcg/min titrating by 5 mcg/min — for ACS/acute pulmonary oedema; tachyphylaxis), CLEVIDIPINE (ultra-short DHP CCB — 1 min half-life — esterase-metabolised; VELOCITY trial: 2 mg/h start, doubled every 3 min to 32 mg/h), ESMOLOL (beta-1 selective — 500 mcg/kg load then up to 100 mcg/kg/min — aortic dissection, tachyarrhythmia), FENOLDOPAM (D1 agonist — 0.1 mcg/kg/min start — 'renal protective' claim unproven), PHENTOLAMINE (non-selective alpha-blocker — 5 mg IV bolus — pheochromocytoma crisis FIRST). Oral agents for chronic ICU BP control (ACEi/ARB, CCB, beta-blockers, diuretics, alpha-blockers). Scenario-specific rules that MUST be memorised: AORTIC DISSECTION = beta-blocker FIRST then vasodilator (prevent reflex tachycardia → propagation; target HR <60, SBP <120); HYPERTENSIVE ENCEPHALOPATHY = labetalol or nicardipine (BP down ~10% first hour, another ~15% over 2-3 h); PRE-ECLAMPSIA = hydralazine or labetalol + magnesium sulphate; PHEOCHROMOCYTOMA = phentolamine FIRST then beta-blocker (alpha before beta); COCAINE = benzodiazepines FIRST (avoid beta-blockers — unopposed alpha).

high33 referencesUpdated 26 July 202628 min readSource-verified · Sept 2026

Checked against its sources on 3 Sept 2026

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • PHEOCHROMOCYTOMA crisis: NEVER give a beta-blocker before an alpha-blocker — beta-blockade leaves catecholamine alpha-1 vasoconstriction UNOPPOSED → catastrophic worsening hypertension + pulmonary oedema. Always phentolamine (alpha-blocker) FIRST, then add beta-blocker.
  • AORTIC DISSECTION: ALWAYS give a beta-blocker FIRST (target HR &lt;60) BEFORE any vasodilator. Vasodilator alone → reflex tachycardia → increased dP/dt → propagation of the dissection flap.
  • COCAINE-induced hypertension: AVOID beta-blockers (unopposed alpha → vasospasm, paradoxical hypertension). Use BENZODIAZEPINES first-line.
  • SODIUM NITROPRUSSIDE: CYANIDE TOXICITY risk rises with infusion rate, cumulative dose, prolonged duration, or renal/hepatic impairment — rising lactate + metabolic acidosis + normal PaO2 (venous hyperoxia); can present late, even after the infusion is stopped. Antidote: sodium thiosulfate + hydroxocobalamin.
  • Do NOT use SUBlingual nifedipine (unpredictable precipitous BP drop → stroke/MI/organ ischaemia) — withdrawn from use.
On this page
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • PHEOCHROMOCYTOMA crisis: NEVER give a beta-blocker before an alpha-blocker — beta-blockade leaves catecholamine alpha-1 vasoconstriction UNOPPOSED → catastrophic worsening hypertension + pulmonary oedema. Always phentolamine (alpha-blocker) FIRST, then add beta-blocker.
  • AORTIC DISSECTION: ALWAYS give a beta-blocker FIRST (target HR &lt;60) BEFORE any vasodilator. Vasodilator alone → reflex tachycardia → increased dP/dt → propagation of the dissection flap.
  • COCAINE-induced hypertension: AVOID beta-blockers (unopposed alpha → vasospasm, paradoxical hypertension). Use BENZODIAZEPINES first-line.
  • SODIUM NITROPRUSSIDE: CYANIDE TOXICITY risk rises with infusion rate, cumulative dose, prolonged duration, or renal/hepatic impairment — rising lactate + metabolic acidosis + normal PaO2 (venous hyperoxia); can present late, even after the infusion is stopped. Antidote: sodium thiosulfate + hydroxocobalamin.
  • Do NOT use SUBlingual nifedipine (unpredictable precipitous BP drop → stroke/MI/organ ischaemia) — withdrawn from use.

Overview & definition

The one-paragraph exam answer

A hypertensive emergency is severe BP elevation WITH acute hypertension-mediated organ damage (HMOD) — it requires ICU admission + immediate (but CONTROLLED) BP reduction with a titratable IV agent. A hypertensive urgency is severe BP WITHOUT acute organ damage — managed with ORAL agents, no ICU. The chosen drug, target BP and timeframe are dictated by the type of organ damage. The IV agents: LABETALOL (alpha+beta — versatile first-line; RCT regimen 20 mg IV bolus, then 40 mg, then 80 mg every 20 min to a 300 mg maximum — pregnancy-safe), NICARDIPINE (DHP-CCB infusion 5-15 mg/h — smooth, titratable — stroke/most emergencies), CLEVIDIPINE (ultra-short DHP — t½ ≈1 min — doubled every 3 min from 2 mg/h to a 32 mg/h maximum — ester metabolism), ESMOLOL (beta-1 selective; 500 mcg/kg bolus then up to 100 mcg/kg/min — aortic dissection), HYDRALAZINE (direct arteriolar vasodilator — 5 mg slow IV bolus repeatable — pre-eclampsia; reflex tachycardia), NITROGLYCERIN (venous NO donor — 5 mcg/min start, titrated by 5 mcg/min every 3-5 min — ACS/pulmonary oedema), SODIUM NITROPRUSSIDE (arteriolar+venous NO — most potent; 0.5 mcg/kg/min start — CYANIDE toxicity risk escalates with rate, cumulative dose or prolonged infusion), FENOLDOPAM (D1 agonist — 0.1 mcg/kg/min start; renal-protective claim unproven), PHENTOLAMINE (alpha-blocker — 5 mg IV bolus — pheochromocytoma). The non-negotiable scenario rules: aortic dissection → beta-blocker FIRST (HR <60) then vasodilator (SBP <120); pheochromocytoma → phentolamine (alpha) FIRST then beta-blocker (alpha before beta, never beta alone); cocaine → benzodiazepines first, AVOID beta-blockers. General target: lower BP by about 10% in the first hour, then a further ~15% over 2-3 h (exception: aortic dissection — rapid to SBP <120).[2][6][7][8][10][11][12][15][16][18][22][23]

ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References33ShowHide
  1. [1]Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Hypertension, 2018.PMID 29133356
  2. [2]van den Born BH, Lip GYH, Brguljan-Hitij J, et al. ESC Council on hypertension position document on the management of hypertensive emergencies Eur Heart J Cardiovasc Pharmacother, 2019.PMID 30165588
  3. [3]Perez MI, Musini VM. Pharmacological interventions for hypertensive emergencies Cochrane Database Syst Rev, 2008.PMID 18254026
  4. [4]Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine Circulation, 2010.PMID 20233780
  5. [5]Varon J. Treatment of acute severe hypertension: current and newer agents Drugs, 2008.PMID 18257607
  6. [6]Varon J, Marik PE Clinical review: the management of hypertensive crises Crit Care, 2003.PMID 12974970
  7. [7]Vigil-De Gracia P, Lasso M, Ruiz E, et al. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial Eur J Obstet Gynecol Reprod Biol, 2006.PMID 16621226
  8. [8]Frank Peacock W 4th, Varon J, Ebrahimi R, et al. Clevidipine for severe hypertension in patients with renal dysfunction: a VELOCITY trial analysis Blood Press Suppl, 2011.PMID 21091269
  9. [9]Kenyon KW Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension Ann Pharmacother, 2009.PMID 19584385
  10. [10]Koga M, Arihiro S, Hasegawa Y, et al. Intravenous nicardipine dosing for blood pressure lowering in acute intracerebral hemorrhage: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study J Stroke Cerebrovasc Dis, 2014.PMID 25314943
  11. [11]Narotam PK, Puri V, Roberts JM, et al. Management of hypertensive emergencies in acute brain disease: evaluation of the treatment effects of intravenous nicardipine on cerebral oxygenation J Neurosurg, 2008.PMID 19035721
  12. [12]Tempe DK, Mulchandani P, Tandon MS, et al. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol Indian Heart J, 1999.PMID 10624069
  13. [13]Krenz JR, O'Brien ME, Lee J, et al. Evaluation of esmolol for heart rate control in patients with acute aortic dissection Am J Emerg Med, 2021.PMID 32354528
  14. [14]Liu G, Wang D, Yang Y, et al. Efficacy and Safety of preoperative Controlling Heart Rate in Patients with Acute Type A Aortic Dissection (ESCORT): protocol for a randomised controlled trial BMJ Open, 2026.PMID 41962972
  15. [15]Henry K, Pelsue B, Hartman H, et al. Low versus high dosing strategies of intravenous nitroglycerin for the management of sympathetic crashing acute pulmonary edema Am J Emerg Med, 2025.PMID 40834833
  16. [16]Pilmer BL, Green JA, Panacek EA, et al. Fenoldopam mesylate versus sodium nitroprusside in the acute management of severe systemic hypertension J Clin Pharmacol, 1993.PMID 8103527
  17. [17]Broderick KE, Balasubramanian M, Chan A, et al. The cobalamin precursor cobinamide detoxifies nitroprusside-generated cyanide Exp Biol Med (Maywood), 2007.PMID 17526771
  18. [18]du Cailar J, Mathieu-Daudé JC, Deschodt J, et al. [Plasma level of the thiocyanate ion in sodium nitroprusside perfusion]. Ann Anesthesiol Fr, 1976.PMID 10791
  19. [19]Fog L, Pedersen OL [Hypertensive crises. 2. Treatment]. Ugeskr Laeger, 1995.PMID 8545929
  20. [20]Morris AA, Page RL 2nd, Baumgartner LJ, et al. Thiocyanate Accumulation in Critically Ill Patients Receiving Nitroprusside Infusions J Intensive Care Med, 2017.PMID 27435907
  21. [21]Udeh CI, Ting M, Arango M, et al. Delayed presentation of nitroprusside-induced cyanide toxicity Ann Thorac Surg, 2015.PMID 25841829
  22. [22]Elliott WJ Clinical features and management of selected hypertensive emergencies J Clin Hypertens (Greenwich), 2004.PMID 15470289
  23. [23]Myklejord DJ Undiagnosed pheochromocytoma: the anesthesiologist nightmare Clin Med Res, 2004.PMID 15931336
  24. [24]Richards JR, Garber D, Laurin EG, et al. Treatment of cocaine cardiovascular toxicity: a systematic review Clin Toxicol (Phila), 2016.PMID 26919414
  25. [25]Khan NN, Zurayyir EJ, Alghamdi AM, et al. Management Strategies for Hypertensive Crisis: A Systematic Review Cureus, 2024.PMID 39262522
  26. [26]Rose JC, Mayer SA Optimizing blood pressure in neurological emergencies Neurocrit Care, 2004.PMID 16174926
  27. [27]Stetson JB, Reading GP Avoidance of vascular complications associated with the use of dopamine Can Anaesth Soc J, 1977.PMID 201354
  28. [28]Saldana S, Breslin J 2nd, Hanify J, et al. Comparison of Clevidipine and Nicardipine for Acute Blood Pressure Reduction in Hemorrhagic Stroke Neurocrit Care, 2022.PMID 34904214
  29. [29]Liu C, Lv Q, Chen X, et al. Preoperative selective vs non-selective α-blockade in PPGL patients undergoing adrenalectomy Endocr Connect, 2017.PMID 28986400
  30. [30]Misra M, Chembale J, Kankane A Evaluation of the efficacy, safety and tolerability of intravenous enalaprilat in the treatment of grade III essential hypertension in Indian patients Indian Heart J, 2004.PMID 15129797
  31. [31]Borghi C, Cicero AF, Agnoletti D, et al. Pathophysiology of cough with angiotensin-converting enzyme inhibitors: How to explain within-class differences? Eur J Intern Med, 2023.PMID 36628825
  32. [32]Sandweiss AJ, Morrison CM, Spichler A, et al. A case report of clonidine induced syncope: a review of central actions of an old antihypertensive BMC Pharmacol Toxicol, 2018.PMID 29433586
  33. [33]Xiao X, Chang C Diagnosis and classification of drug-induced autoimmunity (DIA) J Autoimmun, 2014.PMID 24456934

Test yourself

Practise what you just read

  • 8 MCQs
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousICU Antibiotic Pharmacology — Comprehensive (PK/PD in Critical Illness)pharmacologyNextICU Corticosteroids — Comprehensive Pharmacology (Glucocorticoids in Critical Illness)pharmacology